Cascade Reactions for Biologically Active Natural Products

Information

  • Research Project
  • 10259759
  • ApplicationId
    10259759
  • Core Project Number
    R01GM140183
  • Full Project Number
    5R01GM140183-02
  • Serial Number
    140183
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    9/20/2020 - 4 years ago
  • Project End Date
    8/31/2024 - 8 months ago
  • Program Officer Name
    YANG, JIONG
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/25/2021 - 3 years ago
Organizations

Cascade Reactions for Biologically Active Natural Products

Homoharringtonine (HHT) is a clinically used protein translation inhibitor that is used to treat chronic myeloid leukemia. In addition to its FDA-approved role as a leukemia drug, HHT shows exciting promise for the treatment of other hematologic malignancies and tumors. Finally, it is a perfect molecule to use as a probe to investigate protein translation inhibition. HHT is currently prepared through semi-synthesis from naturally derived cephalotaxine. Cephalotaxine is obtained from Asian plum yew trees grown in China. The cost of HHT in particular, along with other leukemia treatments, has been described as ?astronomical? and ?harmful to patients? by a group of 100 leading cancer specialists. This cost results in part from a supply bottleneck reflecting its tree-based sourcing. This project will completely eliminate this supply problem, and provide cephalotaxine and HHT for our studies and those by other research groups. Natural products have been the source of the majority of drugs throughout history, and still are today. The field of chemical synthesis directly contributes to the application of natural products as medicines. Aromatic and heteroaromatic rings are indispensible motifs in biologically active compounds. Thus, chemical reactions that allow for the construction of molecular architectures containing substituted aromatic rings are particularly valuable to human health. Polycyclic nitrogenous molecules, exemplified by the Cephalotaxus alkaloids in this proposal, are also critically important as biologically active molecules and pharmaceuticals. However, polycyclic nitrogenous molecules, such as alkaloids, are notoriously difficult to prepare, often requiring arduous chemical syntheses for preparation. We will develop two new cascade reactions that efficiently prepare: 1. Substituted arenes, and 2. Complex polycyclic alkaloids. The innovativeness of this research is the strategic use of cascade reactions to assemble structures that previously required multiple steps to prepare. A distinguishing feature of this strategy is its inherent efficiency. Additionally, we will showcase these pericyclic cascades in syntheses of natural products and natural product analogs. More widely, this strategy will find immediate application in the preparation of biologically active molecules, such as HHT; chemical probes for biological systems, and related molecules.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    175000
  • Indirect Cost Amount
    70212
  • Total Cost
    245212
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIGMS:245212\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    SBCB
  • Study Section Name
    Synthetic and Biological Chemistry B Study Section
  • Organization Name
    OREGON STATE UNIVERSITY
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    053599908
  • Organization City
    CORVALLIS
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    973318555
  • Organization District
    UNITED STATES